Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
58.3%
% of BBH's 26 holdings also in XBI
11.9%
% of XBI's 119 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 5.2% | 2.8% | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 12.6% | 2.7% | 2.7% |
|
INSMED INC | 2.7% | 2.7% | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 4.3% | 2.7% | 2.7% |
|
GILEAD SCIENCES INC | 13.2% | 2.5% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to XBI
|
AMGEN INC | 14.0% |
|
GILEAD SCIENCES INC | 10.7% |
|
VERTEX PHARMACEUTICALS INC | 9.8% |
 |
ARGENX SE ADR | 5.8% |
|
IQVIA HOLDINGS INC | 4.0% |
 |
ICON PLC | 3.2% |
|
REGENERON PHARMACEUTICALS | 2.9% |
 |
BIONTECH SE SPONSORED ADR | 2.8% |
|
ILLUMINA INC | 2.7% |
|
NATERA INC | 2.4% |
BBH Underweight Relative to XBI
|
UNITED THERAPEUTICS CORP | -2.6% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.3% |
|
ABBVIE INC | -2.3% |
|
BLUEPRINT MEDICINES CORP. | -2.2% |
|
EXELIXIS INC | -2.1% |
|
TG THERAPEUTICS INC | -1.8% |
|
BRIDGEBIO PHARMA, INC. | -1.8% |
|
HALOZYME THERAPEUTICS INC | -1.7% |
|
REVOLUTION MEDICINES, INC. | -1.5% |
|
CYTOKINETICS INC | -1.5% |